Clinical Trial

Terazosin And Metabolic Energetics in Parkinson's Disease

Study acronym: TAME-PD:
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study investigates if Terazosin can improve metabolism in PD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-05.
Trial Details
NCT Number NCT07464028
Lead Sponsor Nandakumar Narayanan
Conditions Parkinson's Disease (PD)
Enrollment 120 participants
Start Date 2026-07-01
Primary Completion 2030-07-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16